375 related articles for article (PubMed ID: 10321595)
21. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
22. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater.
Wainwright NJ; MacLeod TM; Ferguson J
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123
[TBL] [Abstract][Full Text] [Related]
23. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
24. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles.
Behrens S; von Kobyletzki G; Gruss C; Reuther T; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):47-51. PubMed ID: 10321515
[TBL] [Abstract][Full Text] [Related]
25. [Cream PUVA photochemotherapy].
Stege H; Berneburg M; Ruzicka T; Krutmann J
Hautarzt; 1997 Feb; 48(2):89-93. PubMed ID: 9173066
[TBL] [Abstract][Full Text] [Related]
26. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
[TBL] [Abstract][Full Text] [Related]
27. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
28. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
29. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Calzavara-Pinton P
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
[TBL] [Abstract][Full Text] [Related]
30. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
32. Randomized double-blind comparative study of 8-methoxypsoralen bath plus UV-A treatment regimens.
Berroeta L; Man I; Dawe RS; Ferguson J; Ibbotson SH
Actas Dermosifiliogr; 2010 Oct; 101(8):729-30. PubMed ID: 20965019
[No Abstract] [Full Text] [Related]
33. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.
Godt O; Proksch E; Streit V; Christophers E
Dermatology; 1997; 195(1):35-9. PubMed ID: 9267734
[TBL] [Abstract][Full Text] [Related]
34. Bath-water delivery of 8-methoxypsoralen therapy for psoriasis.
Collins P; Rogers S
Clin Exp Dermatol; 1991 May; 16(3):165-7. PubMed ID: 1934565
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
[TBL] [Abstract][Full Text] [Related]
36. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
37. PUVA and cancer risk: the Swedish follow-up study.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
[TBL] [Abstract][Full Text] [Related]
38. Can the immersion time of PUVA bath therapy be shortened?
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Acta Derm Venereol; 2002; 82(1):18-20. PubMed ID: 12013191
[TBL] [Abstract][Full Text] [Related]
39. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis.
Cooper EJ; Herd RM; Priestley GC; Hunter JA
Clin Exp Dermatol; 2000 Mar; 25(2):111-4. PubMed ID: 10733632
[TBL] [Abstract][Full Text] [Related]
40. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
